bpc-157 for rheumatoid arthritis Benefits, Dosage & Before/After Results Has anyone tried bpc-157 for

People with soft-tissue injuries affecting their tendons, ligaments, or muscles are the most likely candidates

Supports migration of repair cells to injured tissue

ClinicalTrials.gov

It is hard to know how often these are truly caused by the peptides

you can buy whichever products you want and skip the rest

Its compounding-pathway status is unsettled: ibutamoren mesylate was nominated for inclusion on FDA's Section 503A bulk drug substances list, and the Pharmacy Compounding Advisory Committee reviewed the nomination at its October 29, 2024 meeting and voted against recommending it for the list, citing concerns about the strength of the safety and efficacy evidence